4.5 Article

The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice

期刊

JOURNAL OF APPLIED PHYSIOLOGY
卷 110, 期 6, 页码 1656-1663

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/japplphysiol.01425.2010

关键词

passive properties; skeletal muscle; muscular dystrophy; dystrophin; myotendinous junction

资金

  1. National Institutes of Health (NIH) [AR-49419, T90-DK-70105]
  2. Muscular Dystrophy Association

向作者/读者索取更多资源

Muscle rigidity and myotendinous junction (MTJ) deficiency contribute to immobilization in Duchenne muscular dystrophy (DMD), a lethal disease caused by the absence of dystrophin. However, little is known about the muscle passive properties and MTJ strength in a diseased muscle. Here, we hypothesize that dystrophin-deficient muscle pathology renders skeletal muscle stiffer and MTJ weaker. To test our hypothesis, we examined the passive properties of an intact noncontracting muscle-tendon unit in mdx mice, a mouse model for DMD. The extensor digitorum longus (EDL) muscle-tendon preparations of 2-, 6-, 14-, and 20-mo-old mdx and normal control mice were strained stepwisely from 110% to 160% of the muscle optimal length. The stress-strain response and failure position were analyzed. In support of our hypothesis, the mdx EDL preparation consistently developed higher stress before muscle failure. Postfailure stresses decreased dramatically in mdx but not normal preparations. Further, mdx showed a significantly faster stress relaxation rate. Consistent with stress-strain assay results, we observed significantly higher fibrosis in mdx muscle. In 2- and 6-mo-old mdx and 20-mo-old BL10 mice failure occurred within the muscle (2- to 14-mo-old BL10 preparations did not fail). Interestingly, in >= 14-mo-old mdx mice the failure site shifted toward the MTJ. Electron microscopy revealed substantial MTJ degeneration in aged but not young mdx mice. In summary, our results suggest that the passive properties of the EDL muscle and the strength of MTJ are compromised in mdx in an age-dependent manner. These findings offer new insights in studying DMD pathogenesis and developing novel therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Potential cross-talk between muscle and tendon in Duchenne muscular dystrophy

Claire Yuan, Ashwin Arora, Anthony M. Garofalo, Robert W. Grange

Summary: This study explores the potential signaling between dystrophic skeletal muscle and tendon in Duchenne muscular dystrophy, focusing on the cross-talk at the myotendinous junction. The absence of dystrophin and the associated dystrophin-glycoprotein complex is a key feature of Duchenne muscular dystrophy, with other potential signal pathways contributing to the cross-talk between muscle and tendon.

CONNECTIVE TISSUE RESEARCH (2021)

Article Veterinary Sciences

Widespread severe myodegeneration in a compound heterozygote female dog with dystrophin deficiency

Jessica S. Fortin, Chady H. Hakim, Scott Korte, N. Nora Yang, Scott D. Fitzgerald, Gayle C. Johnson, Bruce F. Smith, Dongsheng Duan

Summary: The University of Missouri established a colony of dystrophin-deficient dogs to study the genetic and molecular basis of dystrophinopathies, focusing on a female dog with abnormal genotype and phenotype, which displayed skeletal and muscle abnormalities. This case highlighted the importance of studying dystrophinopathy in female dogs without a normal X chromosome for effective therapeutic strategies.

VETERINARY MEDICINE AND SCIENCE (2021)

Article Physiology

A novel murine muscle loading model to investigate Achilles musculotendinous adaptation

Sabah N. Rezvani, Anne E. C. Nichols, Robert W. Grange, Linda A. Dahlgren, P. Gunnar Brolinson, Vincent M. Wang

Summary: Achilles tendinopathy is a challenging condition with limited effective therapies. This study introduced a novel mouse model of hindlimb muscle loading for targeted therapeutic exercise, showing promising results in improving biomechanical outcomes in a murine tendinopathy model. This model opens up possibilities for further research on how muscle loading can enhance healing of Achilles tendon injuries.

JOURNAL OF APPLIED PHYSIOLOGY (2021)

Article Medicine, Research & Experimental

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice

Shelby E. Hamm, Daniel D. Fathalikhani, Katherine E. Bukovec, Adele K. Addington, Haiyan Zhang, Justin B. Perry, Ryan P. McMillan, Michael W. Lawlor, Mariah J. Prom, Mark A. Vanden Avond, Suresh N. Kumar, Kirsten E. Coleman, J. B. Dupont, David L. Mack, David A. Brown, Carl A. Morris, J. Patrick Gonzalez, Robert W. Grange

Summary: The study showed that combining voluntary wheel running with microdystrophin gene therapy in young mdx mice improved whole-body performance, affected muscle function to varying degrees, mitigated energy deficits, but also revealed some detrimental effects of exercise.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Oncology

Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy

Kasun Kodippili, Pamela K. Thorne, M. Harold Laughlin, Dongsheng Duan

Summary: Through studying a canine DMD model, this research found that dystrophin deficiency leads to structural remodeling of the artery and impaired vascular function, suggesting that dystrophin plays a crucial role in maintaining the structure and function of vascular endothelium and smooth muscle in large mammals. Vascular defects may contribute to DMD pathogenesis.

JOURNAL OF PATHOLOGY (2021)

Article Cell Biology

Extensor carpi ulnaris muscle shows unexpected slow-to-fast fiber-type switch in Duchenne muscular dystrophy dogs

Chady H. Hakim, Hsiao T. Yang, Matthew J. Burke, James Teixeira, Gregory J. Jenkins, N. Nora Yang, Gang Yao, Dongsheng Duan

Summary: By studying aged dystrophin-null canines' muscle pathology and contractile properties, we established a foundation for using this model in research on experimental therapies for Duchenne muscular dystrophy, revealing an unexpected myofiber-type switch in affected dogs.

DISEASE MODELS & MECHANISMS (2021)

Article Biochemistry & Molecular Biology

Rational engineering of a functional CpG-free ITR for AAV gene therapy

Xiufang Pan, Yongping Yue, Maria Boftsi, Lakmini P. Wasala, Ngoc Tam Tran, Keqing Zhang, David J. Pintel, Phillip W. L. Tai, Dongsheng Duan

Summary: The study found that complete elimination of CpG motifs in the ITR does not impact the biological activity of the AAV vector. CpG-free ITRs could be valuable in engineering therapeutic AAV vectors.

GENE THERAPY (2022)

Article Nutrition & Dietetics

Dietary Conjugated Linoleic Acid Reduces Body Weight and Fat in Snord116m+/p- and Snord116m-/p- Mouse Models of Prader-Willi Syndrome

Brittney Knott, Matthew A. Kocher, Henry A. Paz, Shelby E. Hamm, William Fink, Jordan Mason, Robert W. Grange, Umesh D. Wankhade, Deborah J. Good

Summary: This study demonstrated that Snord116(m+/p-) mice and mice with a deletion of both Snord116 alleles showed weight and fat loss on a high-fat/CLA diet, indicating that the genotype did not interfere with CLA actions. There were no changes in food intake or metabolic rate, and only moderate differences in exercise performance. RNA-seq and microbiome analyses identified hypothalamic mRNAs and differentially populated gut bacteria, supporting future mechanistic analyses.

NUTRIENTS (2022)

Correction Medicine, Research & Experimental

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice (vol 21, pg 144, 2021)

Shelby E. Hamm, Daniel D. Fathalikhani, Katherine E. Bukovec, Adele K. Addington, Haiyan Zhang, Justin B. Perry, Ryan P. McMillan, Michael W. Lawlor, Mariah J. Prom, Mark A. Vanden Avond, Suresh N. Kumar, Kirsten E. Coleman, J. B. Dupont, David L. Mack, David A. Brown, Carl A. Morris, J. Patrick Gonzalez, Robert W. Grange

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Letter Cardiac & Cardiovascular Systems

Letter by Duan et al Regarding Article, Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy In Vivo

Dongsheng Duan, Kevin M. Flanigan, Annemieke Aartsma-Rus

CIRCULATION (2022)

Article Biotechnology & Applied Microbiology

The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy

Nalinda B. Wasala, Emily D. Million, Thais B. Watkins, Lakmini P. Wasala, Jin Han, Yongping Yue, Baisong Lu, Shi-jie Chen, Chady H. Hakim, Dongsheng Duan

Summary: Short-term local injection of CRISPR editing technique can restore dystrophin in DMD patients, while long-term systemic injection failed. The study found that long-term systemic injection resulted in selective loss of gRNA vector, which was not affected by the injection time and dosage. In addition, a higher dose of gRNA vector was associated with better therapeutic effects.

HUMAN GENE THERAPY (2022)

Letter Cardiac & Cardiovascular Systems

Microdystrophin Therapy Rescues Impaired Na Currents in Cardiac Purkinje Fibers From Dystrophin-Deficient Mdx Mice

Janine Ebner, Xiufang Pan, Yongping Yue, Spyridon Sideromenos, Jessica Marksteiner, Xaver Koenig, Karlheinz Hilber, Dongsheng Duan

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2022)

Article Biotechnology & Applied Microbiology

The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy

Lakmini P. Wasala, Thais B. Watkins, Nalinda B. Wasala, Matthew J. Burke, Yongping Yue, Yi Lai, Gang Yao, Dongsheng Duan

Summary: Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by dystrophin deficiency. In this study, it was found that mu Dys with both H1 and H4 effectively localized to the muscle membrane, restored the dystrophin-associated protein complex, and improved muscle force. On the other hand, mu Dys with only H1 or without H4 did not have the same effects. Therefore, H4 is essential for mu Dys function and H1 facilitates force production. These findings will contribute to the development of next-generation mu Dys gene therapy.

HUMAN GENE THERAPY (2023)

Article Biotechnology & Applied Microbiology

Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model

Nalinda B. Wasala, Yongping Yue, Bryan Hu, Jin-Hong Shin, Gang Yao, Dongsheng Duan

Summary: In this study, the researchers injected the AAV mu Dys vector into mdx mice and observed significant improvements in muscle strength, exercise capacity, and cardiac function. The results suggest that AAV mu Dys therapy has the potential to provide lifelong benefits in patients with Duchenne muscular dystrophy.

HUMAN GENE THERAPY (2023)

Review Biotechnology & Applied Microbiology

Lethal immunotoxicity in high-dose systemic AAV therapy

Dongsheng Duan

Summary: This mini-review summarizes clinical findings of lethal immunotoxicity induced by high-dose systemic AAV gene therapy and calls for collaborative efforts to better understand the underlying mechanisms and develop effective prevention/treatment strategies.

MOLECULAR THERAPY (2023)

暂无数据